RESUMEN

Existen diferentes trastornos que afectan el control central de la respiración y se manifiestan durante el dormir como apneas centrales. Aunque se conoce mucho de la fisiopatología y etiopatogenia de los diferentes síndromes de apnea central, aún no se han logrado develar todas sus características; asimismo, no se conoce la importancia de las neuroinfecciones en la disrupción de los mecanismos normales del control central de la respiración durante la noche. A continuación se presenta el caso de una mujer con afección neurológica por enfermedad de Lyme y uso crónico de opioides que causó modificaciones en la homeostasis respiratoria durante el sueño y que se resolvieron con uso de un dispositivo de presión positiva continua en la vía aérea.

PALABRAS CLAVE

Enfermedad de Lyme, apnea obstructiva del sueño, apnea central del sueño, opioides.

REFERENCIAS

1. Berry RB, Brooks R, Garnaldo CE, Harding SM. Marcus CL and Vaughn BU for the American Academy of Sleep Medicine. The AASM Manual for the Scoring of Sleep and Associated Events, Rules, Terminology and Technical Specifications. Version 2.3. www.aasmnet.org, Darien, Illinois: American Academy of Sleep Medicine; 2012.

2. American Academy of Sleep Medicine. International Classification of Sleep Disorders. 3rd ed. Darien II: American Academy of Sleep Medicine; 2014.

3. Marques A. Chronic Lyme disease: a review. Infect Dis Clin North Am 2008;22(2):341-360, vii-viii. doi: 10.1016/j.idc.2007.12.011.

4. Badr MS, Skatrud JB, Dempsey JA. Determinants of post-stimulus potentiation in humans during NREM sleep. J Appl Physiol (1985) 1992;73(5):1958-1971.

5. Eldridge FL. Central neural respiratory stimulatory effect of active respiration. J Appl Physiol 1974;37(5):723-735.

6. Horner RL, Sanford LD, Pack AI, Morrison AR. Activation of a distinct arousal state immediately after spontaneous awakening from sleep. Brain Res 1997;778(1):127-134.

7. Xie A, Wong B, Phillipson EA, Slutsky AS, Bradley TD. Interaction of hyperventilation and arousal in the pathogenesis of idiopathic central sleep apnea. Am J Respir Crit Care Med 1994;150(2):489-495.

8. Younes M. Role of arousals in the pathogenesis of obstructive sleep apnea. Am J Respir Crit Care Med 2004;169(5):623-633.

9. Dauger S, Pattyn A, Lofaso F, et al. Phox2b controls the development of peripheral chemoreceptors and afferent visceral pathways. Development 2003;130(26):6635-6642.

10. Takakura AC, Moreira TS, Colombari E, West GH, Stornetta RL, Guyenet PG. Peripheral chemoreceptor inputs to retrotrapezoid nucleus (RTN) CO2-sensitive neurons in rats. J Physiol 2006;572(Pt 2):503-523.

11. Stornetta RL, Moreira TS, Takakura AC, et al. Expression of Phox2b by brainstem neurons involved in chemosensory integration in the adult rat. J Neurosci 2006;26(40):10305-10314.

12. Dempsey JA, Veasey SC, Morgan BJ, O’Donnell CP. Pathophysiology of sleep apnea. Physiol Rev 2010;90(1):47-112. doi: 10.1152/physrev.00043.2008.

13. Hanly PJ, Millar TW, Steljes DG, Baert R, Frais MA, Kryger MH. Respiration and abnormal sleep in patients with congestive heart failure. Chest 1989;96(3):480-488.

14. Orem J. Central respiratory activity in rapid eye movement sleep: augmenting and late inspiratory cells. Sleep 1994;17(8):665-673.

15. Khoo MC, Kronauer RE, Strohl KP, Slutsky AS. Factors inducing periodic breathing in humans: a general model. J Appl Physiol Respir Environ Exerc Physiol 1982;53(3):644-659.

16. Gay PC. Complex sleep apnea: it really is a disease. J Clin Sleep Med 2008;4(5):403-405.

17. Cherniack NS, Longobardo GS. Mathematical models of periodic breathing and their usefulness in understanding cardiovascular and respiratory disorders. Exp Physiol 2006;91(2):295-305.

18. Khoo MC. Determinants of ventilatory instability and variability. Respir Physiol 2000;122(2-3):167-182.

19. Malhotra A, Bertisch S, Wellman A. Complex sleep apnea: it isn’t really a disease. J Clin Sleep Med 2008;4(5):406-408.

20. Dernaika T, Tawk M, Nazir S, Younis W, Kinasewitz GT. The significance and outcome of continuous positive airway pressure related central sleep apnea during split-night sleep studies. Chest 2007;132(1):81-87.

21. Javaheri S, Smith J, Chung E. The prevalence and natural history of complex sleep apnea. J Clin Sleep Med 2009;5(3):205-211.

22. Morgenthaler TI, Kagramanov V, Hanak V, Decker PA. Complex sleep apnea syndrome: is it a unique clinical syndrome? Sleep 2006;29(9):1203-1209.

23. Lehman S, Antic NA, Thompson C, Catcheside PG, Mercer J, McEvoy RD. Central sleep apnea on commencement of continuous positive airway pressure in patients with a primary diagnosis of obstructive sleep apnea-hypopnea. J Clin Sleep Med 2007;3(5):462-466.

24. White DP. Central sleep apnea. Med Clin North Am 1985;69(6):1205-1219.

25. Kushida CA, Chediak A, Berry RB, et al.; Positive Airway Pressure Titration Task Force; American Academy of Sleep Medicine. Clinical guidelines for the manual titration of positive airway pressure in patients with obstructive sleep apnea. J Clin Sleep Med 2008;4(2):157-171.

26. White DP, Zwillich CW, Pickett CK, Douglas NJ, Findley LJ, Weil JV. Central sleep apnea. Improvement with acetazolamide therapy. Arch Intern Med 1982;142(10):1816-1819.

27. Elliott AM, Smith BH, Penny KI, Smith WC, Chambers WA. The epidemiology of chronic pain in the community. Lancet 1999;354(9186):1248-1252.

28. Eckert DJ, Jordan AS, Merchia P, Malhotra A. Central sleep apnea: pathophysiology and treatment. Chest 2007;131(2):595-607.

29. Shook JE, Watkins WD, Camporesi EM. Differential roles of opioid receptors in respiration, respiratory disease, and opiate-induced respiratory depression. Am Rev Respir Dis 1990;142(4):895-909.

30. Javaheri S, Malik A, Smith J, Chung E. Adaptive pressure support servoventilation: a novel treatment for sleep apnea associated with use of opioids. J Clin Sleep Med 2008;4(4):305-310.

31. Greenberg HE, Ney G, Scharf SM, Ravdin L, Hilton E. Sleep quality in Lyme disease. Sleep 1995;18(10):912-916.